Telix Pharmaceuticals | TLX - Trade Debtors

Stock Price
10.00
Daily Change
-0.20 -1.96%
Monthly
-14.16%
Yearly
-64.86%
Q1 Forecast
10.21

Telix Pharmaceuticals reported AUD135.24M in Trade Debtors for its fiscal semester ending in December of 2025.





Trade Debtors Change Date
Cochlear AUD 585.9M 72.2M Jun/2025
CSL USD 2.97B 638M Jun/2025
Integral Diagnostics AUD 24.82M 10.78M Jun/2024
Mayne Pharma AUD 193.22M 5.64M Jun/2024
Medical Developments International AUD 7.65M 162K Jun/2025
Mesoblast USD 43.3M 28.43M Dec/2025
Neuren Pharmaceuticals AUD 20.71M 155.01M Jun/2025
Pacific Edge NZD 3.75M 1.22M Dec/2025
Paradigm Biopharmaceuticals AUD 6.37M 4.2K Jun/2025
Polynovo AUD 20.72M 5.22M Jun/2024
PYC Therapeutics AUD 24.07M 11.8M Jun/2025
Ramsay Health Care AUD 2.51B 119.8M Jun/2025
ResMed USD 1.05B 88.62M Dec/2025
Sonic Healthcare AUD 1.39B 23.76M Dec/2024